Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated delayed-rectifier potassium channels are a critical class of transmembrane proteins that facilitate the outward flow of potassium ions in response to membrane depolarization. These channels are distinguished by their delayed activation kinetics and slow inactivation, which are essential for the repolarization phase of the neuronal action potential [1]. By restoring the negative resting membrane potential, they limit the duration of individual action potentials and regulate the frequency of repetitive firing, thereby controlling neuronal excitability and synaptic transmission [2]. In the central nervous system, these channels are primarily composed of subunits from the Kv1 (KCNA), Kv2 (KCNB), and Kv3 (KCNC) families [3]. Mutations in the genes encoding these channels are linked to neurological disorders such as epilepsy, episodic ataxia, and neuropathic pain [1]. Pharmacological agents like dalfampridine (4-aminopyridine) act as blockers of these channels to enhance nerve conduction in conditions like multiple sclerosis, while other research focuses on channel openers to treat hyperexcitability [2]. However, the widespread expression of these channels across various tissues, including the heart, necessitates high subtype selectivity to avoid adverse effects such as cardiac arrhythmias or seizures [3].
Blockade of potassium efflux to prolong action potential duration and enhance synaptic transmission, or activation to hyperpolarize the membrane and reduce excitability.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated potassium channel (Delayed rectifier type) (Kv channel).